Efficacy and safety of 3 mg drospirenone/20 mcg ethinylestradiol oral contraceptive administered in 24/4 regimen in the treatment of acne vulgaris: a randomized, double-blind, placebo-controlled trial
2008 ◽
Vol 77
(4)
◽
pp. 249-256
◽
Keyword(s):
2017 ◽
Vol 56
(6)
◽
pp. 686-690
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2000 ◽
Vol 11
(1)
◽
pp. 7-14
◽
Keyword(s):